190 related articles for article (PubMed ID: 36819776)
1. Identification of Gene Signature-Related Oxidative Stress for Predicting Prognosis of Colorectal Cancer.
Wang X; Chen L; Cao H; Huang J
Oxid Med Cell Longev; 2023; 2023():5385742. PubMed ID: 36819776
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel Immune-Related prognostic model for patients with colorectal cancer based on 3 subtypes.
Yang X; Wei Q
Immunobiology; 2023 Mar; 228(2):152352. PubMed ID: 36827833
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a novel six-gene signature based on mucinous adenocarcinoma-related gene molecular typing in colorectal cancer.
Man Y; Xin D; Ji Y; Liu Y; Kou L; Jiang L
Discov Oncol; 2024 Mar; 15(1):63. PubMed ID: 38443703
[TBL] [Abstract][Full Text] [Related]
6. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive study of oxidative stress-related effects on the prognosis and drug therapy of cervical cancer.
Sheng N; He C; Jin X; Meng Q; Gu P; Ding S; Liu H; Xu Y
J Gene Med; 2024 Jan; 26(1):e3581. PubMed ID: 37605936
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
9. An immune landscape based prognostic signature predicts the immune status and immunotherapeutic responses of patients with colorectal cancer.
Li M; Li W; Yang X; Wang H; Peng Y; Yin J; Lu Y; Liu L; Shang J; Zhao Q
Life Sci; 2020 Nov; 261():118368. PubMed ID: 32888940
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
11. Identification of immune related gene signature for predicting prognosis of cholangiocarcinoma patients.
Zhang ZJ; Huang YP; Liu ZT; Wang YX; Zhou H; Hou KX; Tang JW; Xiong L; Wen Y; Huang SF
Front Immunol; 2023; 14():1028404. PubMed ID: 36817485
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a 7-gene prognostic signature based on oxidative stress genes for predicting chemotherapy resistance in pancreatic cancer.
Zhang S; Yang J; Wu H; Cao T; Ji T
Front Pharmacol; 2023; 14():1091378. PubMed ID: 37138854
[No Abstract] [Full Text] [Related]
13. Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of Cervical Squamous Cell Carcinoma.
Wang L; Qu H; Ma X; Liu X
Oxid Med Cell Longev; 2022; 2022():1056825. PubMed ID: 36225179
[TBL] [Abstract][Full Text] [Related]
14. A Treg-related riskscore model may improve the prognosis evaluation of colorectal cancer.
Li Q; Chu Y; Yao Y; Song Q
J Gene Med; 2024 Feb; 26(2):e3668. PubMed ID: 38342959
[TBL] [Abstract][Full Text] [Related]
15. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
Zhou R; Peng N; Li W
Front Immunol; 2022; 13():964919. PubMed ID: 36059494
[TBL] [Abstract][Full Text] [Related]
16. Identification of an Immune-Related Long Noncoding RNA Pairs Model to Predict Survival and Immune Features in Gastric Cancer.
Song S; Liu S; Wei Z; Jin X; Mao D; He Y; Li B; Zhang C
Front Cell Dev Biol; 2021; 9():726716. PubMed ID: 34621744
[No Abstract] [Full Text] [Related]
17. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
[TBL] [Abstract][Full Text] [Related]
18. Characterization of tumor microenvironment and programmed death-related genes to identify molecular subtypes and drug resistance in pancreatic cancer.
Yu L; He R; Cui Y
Front Pharmacol; 2023; 14():1146280. PubMed ID: 37007021
[No Abstract] [Full Text] [Related]
19. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
